NPS Pharmaceuticals (NPSP -34.9%) sinks after the company reports "adverse events" in a trial of...

|About: NPS Pharmaceuticals, Inc. (NPSP)|By:, SA News Editor

NPS Pharmaceuticals (NPSP -34.9%) sinks after the company reports "adverse events" in a trial of its experimental short bowel syndrome therapy - Gattex - including two patients dying from cancer.